NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

血液透析機用人工血管的全球市場 - 產業預測,綜合分析與預測:2020年∼2026年

Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report - By Raw Material (Polytetrafluoroethylene, Polyester, Biological Materials, and Polyurethane) - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 - 2026

出版商 Zion Market Research 商品編碼 956548
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
血液透析機用人工血管的全球市場 - 產業預測,綜合分析與預測:2020年∼2026年 Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report - By Raw Material (Polytetrafluoroethylene, Polyester, Biological Materials, and Polyurethane) - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 - 2026
出版日期: 2020年08月24日內容資訊: 英文 110 Pages
簡介

全球血液透析機用人工血管市場,2019年達到了約3億1,000萬美元。市場在2020年∼2026年預計以約5.2%的年複合成長率成長。血液透析機用血管通路的功能不全,帶來了血液透析機用人工血管的強大需求。再加上由於腎臟病的發生增加,產品的革新等,近幾年,產品的滲透高漲。

本報告提供全球血液透析機用人工血管市場相關調查分析,市場概要,競爭情形,各市場區隔的市場分析,各地區的市場分析,主要企業等相關的系統性資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 全球血液透析機用人工血管市場:產業分析

  • 血液透析機用人工血管市場:市場動態
  • 推動市場要素
  • 波特的五力分析
  • 市場魅力分析

第4章 全球血液透析機用人工血管市場:競爭情形

  • 企業的市場佔有率分析
  • 策略性開發
  • 價格趨勢分析

第5章 全球血液透析機用人工血管市場:各原料分析

  • 全球血液透析機用人工血管市場概要:各原料
  • 聚四氟乙烯
  • 聚酯
  • 生物材料
  • 聚氨酯

第6章 企業簡介

  • C. R. Bard, Inc.
  • W.L. Gore & Associates
  • LeMaitre Vascular, Inc.
  • Global Bio-Chem Technulogy
  • Terumo Medical Corporation
  • Getinge AB
  • InnAVasc Medical, Inc.
  • Vascular Genesis
  • Merit Medical Systems, Inc.
  • Cryulife, Inc.
  • Proteon Therapeutics, Inc.
目錄

The global Hemodialysis Vascular Grafts market, which accrued nearly 310 (USD Million) in 2019, is set to record the CAGR of nearly 5.2% over the period from 2020 to 2026. The report offers assessment and analysis of the Hemodialysis Vascular Grafts market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, sales estimates, opportunities, evolving trends, and industry-validated data. The report offers historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million).

Introduction

Hemodialysis vascular access dysfunctioning is a key reason for illness in the patients having hemodialysis and it also contributes notably towards total end-phase renal disorder expenses. This has resulted in huge demand for hemodialysis vascular grafts. Moreover, rise in the occurrence of kidney ailments, acceptance of bio-engineered vascular grafts, and product innovations have raised the product penetration in healthcare sector globally in the recent years. Furthermore, less availability of kidney donors has resulted in patients opting for hemodialysis, thereby steering the demand for hemodialysis vascular grafts.

Market Growth Dynamics

A prominent awareness about the advantages of using vascular grafts during hemodialysis procedures for patients with kidney disorders will drive the market growth over the estimated timeframe. In addition to this, patients prefer hemodialysis methods over kidney transplantations due to the huge costs and this will create huge demand for the cost-effective vascular grafts. Apparently, these medical devices facilitate the proper blood flow, thereby ensuring accessibility of huge amount of blood required for performing hemodialysis. This will steer the business growth over the years ahead.

Moreover, due to complications involved due to use of synthetic arteriovenous access grafts during hemodialysis, the demand for biological vascular grafts is gaining traction in hemodialysis as it reduces probabilities of getting infection as well as low chances of rejection. This will create new growth avenues for the market over the years to come. Apparently, improvement in healthcare infrastructure facilities witnessed in the emerging economies will unravel new horizons of growth for hemodialysis vascular grafts industry during the estimated timeline.

North American Market To Amass Huge Returns Over 2020-2026

The growth of the industry in North America during the forecast timespan is owing to huge healthcare spending along with massive utilization of tissue engineered vascular grafts as well as biological vascular grafts during hemodialysis in countries like the U.S. and Canada. Apart from this, rise in the number of patients suffering from chronic renal ailments will enlarge the market scope in the region over the coming years.

Key players leveraging the market growth are InnAVasc Medical, Inc., C. R. Bard, Inc., CryoLife, Inc., W.L. Gore & Associates, LeMaitre Vascular, Inc., Merit Medical Systems, Terumo Medical Corporation, Getinge AB, Vascular Genesis, Inc., and Proteon Therapeutics, Inc.

The global hemodialysis vascular grafts market is segmented as follows:

  • By Raw Material
  • Polyester
  • Polytetrafluoroethylene
  • Polyurethane
  • Biological Materials
  • By Region
  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Contents

Chapter 1. Preface

  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodulogy
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodulogy

Chapter 2. Executive Summary

  • 2.1. Hemodialysis Vascular Grafts Market, 2016–2026(USD Million)
  • 2.2. Hemodialysis Vascular Grafts Market: Snapshot

Chapter 3. Global Hemodialysis Vascular Grafts Market– Industry Analysis

  • 3.1. Hemodialysis Vascular Grafts Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Improvement in healthcare infrastructure facilities witnessed in the emerging economies will unravel new horizons of growth for hemodialysis vascular grafts industry during the estimated timeline.
    • 3.2.2. A prominent awareness about the advantages of using vascular grafts during hemodialysis procedures for patients with kidney disorders will drive the market growth over the estimated timeframe.
  • 3.3. Porter’s Five Forces Analysis
  • 3.4. Market Attractiveness Analysis
    • 3.4.1. Market attractiveness analysis By Raw Material
    • 3.4.2. Market attractiveness analysis By Application

Chapter 4. Global Hemodialysis Vascular Grafts Market– Competitive Landscape

  • 4.1. Company market share analysis
    • 4.1.1. Global Hemodialysis Vascular Grafts Market: company market share, 2019
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New Product launches
    • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis

Chapter 5. Global Hemodialysis Vascular Grafts Market–Raw Material Analysis

  • 5.1. Global Hemodialysis Vascular Grafts Market overview: By Raw Material
    • 5.1.1. Global Hemodialysis Vascular Grafts Market share, By Raw Material , 2019 and 2026
  • 5.2. Pulytetrafluoroethylene
    • 5.2.1. Global Hemodialysis Vascular Grafts Market by Pulytetrafluoroethylene, 2016–2026(USD Million)
  • 5.3. Pulyester
    • 5.3.1. Global Hemodialysis Vascular Grafts Market by Pulyester, 2016–2026(USD Million)
  • 5.4. Biulogical Materials
    • 5.4.1. Global Hemodialysis Vascular Grafts Market by Biulogical Materials, 2016–2026(USD Million)
  • 5.5. Pulyurethane
    • 5.5.1. Global Hemodialysis Vascular Grafts Market by Pulyurethane, 2016–2026(USD Million)

Chapter 6. Company Profiles

  • 6.1. C. R. Bard, Inc.
    • 6.1.1. Overview
    • 6.1.2. Financials
    • 6.1.3. Product Portfulio
    • 6.1.4. Business Strategy
    • 6.1.5. Recent Developments
  • 6.2. W.L. Gore & Associates
    • 6.2.1. Overview
    • 6.2.2. Financials
    • 6.2.3. Product Portfulio
    • 6.2.4. Business Strategy
    • 6.2.5. Recent Developments
  • 6.3. LeMaitre Vascular, Inc.
    • 6.3.1. Overview
    • 6.3.2. Financials
    • 6.3.3. Product Portfulio
    • 6.3.4. Business Strategy
    • 6.3.5. Recent Developments
  • 6.4. Global Bio-Chem Technulogy
    • 6.4.1. Overview
    • 6.4.2. Financials
    • 6.4.3. Product Portfulio
    • 6.4.4. Business Strategy
    • 6.4.5. Recent Developments
  • 6.5. Terumo Medical Corporation
    • 6.5.1. Overview
    • 6.5.2. Financials
    • 6.5.3. Product Portfulio
    • 6.5.4. Business Strategy
    • 6.5.5. Recent Development
  • 6.6. Getinge AB
    • 6.6.1. Overview
    • 6.6.2. Financials
    • 6.6.3. Product Portfulio
    • 6.6.4. Business Strategy
    • 6.6.5. Recent Development
  • 6.7. InnAVasc Medical, Inc.
    • 6.7.1. Overview
    • 6.7.2. Financials
    • 6.7.3. Product Portfulio
    • 6.7.4. Business Strategy
    • 6.7.5. Recent Development
  • 6.8. Vascular Genesis
    • 6.8.1. Overview
    • 6.8.2. Financials
    • 6.8.3. Product Portfulio
    • 6.8.4. Business Strategy
    • 6.8.5. Recent Development
  • 6.9. Merit Medical Systems, Inc.
    • 6.9.1. Overview
    • 6.9.2. Financials
    • 6.9.3. Product Portfulio
    • 6.9.4. Business Strategy
    • 6.9.5. Recent Development
  • 6.10. Cryulife, Inc.
    • 6.10.1. Overview
    • 6.10.2. Financials
    • 6.10.3. Product Portfulio
    • 6.10.4. Business Strategy
    • 6.10.5. Recent Development
  • 6.11. Proteon Therapeutics, Inc.
    • 6.11.1. Overview
    • 6.11.2. Financials
    • 6.11.3. Product Portfulio
    • 6.11.4. Business Strategy
    • 6.11.5. Recent Development